Pharmacology in Rehabilitation Updated Edition
Höfundur:
Charles Ciccone (Útgáfa: 5)
Kaup valmöguleikar
Up-to-date, must-know coverage: Bring your understanding of the rapidly evolving world of pharmacological agents and their impact on rehabilitation up to date with the Updated 5th Edition of the field’s signature reference. An easy-to-understand writing style and easy-to-follow design help you to understand the what, why, and how of this complex subject to ensure the most effective plans of care for your patients.
Nánar um bókina
- F. A. Davis Company
- 9781719645355
- 9781719645348
- ePub
- 5
- Charles Ciccone
- English
- 2022-01-24
- 100
- 25
- 25
Kaflar
- Cover
- Half Title Page
- Title Page
- Copyright Page
- Dedication
- Foreword
- Preface
- Brief Contents
- Contents
- Section 1: General Principles of Pharmacology
- Chapter 1. Basic Principles of Pharmacology
- Relevance of Pharmacology in Rehabilitation
- Drug Nomenclature
- Substitution of Generic Drugs for Brand-Name Products
- What Constitutes a Drug: Development and Approval of Therapeutic Agents
- Drug Approval Process
- Orphan Drugs
- Off-Label Prescribing
- Prescription Versus Over-the-Counter Medication
- Controlled Substances
- Basic Concepts in Drug Therapy
- Dose-Response Curves and Maximal Efficacy
- Potency
- Elements of Drug Safety
- Quantal Dose-Response Curves and the Median Effective Dose
- Median Toxic Dose
- Therapeutic Index
- Summary
- Chapter 2. Pharmacokinetics I: Drug Administration, Absorption, and Distribution
- Routes of Administration
- Enteral
- Parenteral
- Transdermal
- Bioavailability and Drug Absorption Across the Cell Membrane
- Membrane Structure and Function
- Movement Across Membrane Barriers
- Distribution of Drugs Within the Body
- Factors Affecting Distribution
- Volume of Distribution
- Drug Storage
- Storage Sites
- Adverse Consequences of Drug Storage
- Newer Techniques for Drug Delivery
- Controlled-Release Preparations
- Implanted Drug Delivery Systems
- Targeting Drug Delivery to Specific Cells and Tissues
- Summary
- Chapter 3. Pharmacokinetics II: Drug Elimination
- Biotransformation
- Cellular Mechanisms of Drug Biotransformation
- Organs Responsible for Drug Biotransformation: Primary is Liver
- Enzyme Induction
- Drug Excretion
- Drug Elimination Rates
- Clearance
- Half-Life
- Dosing Schedules and Plasma Concentration
- Variations in Drug Response and Metabolism
- Genetics
- Disease
- Drug Interactions
- Age
- Diet
- Gender
- Other Factors
- Summary
- Chapter 4. Pharmacodynamics: Target Tissue Receptors
- Receptors Located on the Cell’s Surface
- Surface Receptors Linked Directly to Ion Channels
- Surface Receptors Linked Directly to Enzymes
- Surface Receptors Linked to Regulatory (G) Proteins and the Role of the Second Messenger
- Intracellular Receptors
- Drug-Receptor Interactions
- Functional Aspects of Drug-Receptor Interactions
- Drug Selectivity and Receptor Subtypes
- Dose-Response
- Classification of Drugs: Agonist Versus Antagonist
- Competitive Versus Noncompetitive Antagonists
- Partial Agonists
- Mixed Agonist-Antagonists and Inverse Agonists
- Receptor Regulation
- Receptor Desensitization and Down-Regulation
- Receptor Supersensitivity
- Nonreceptor Drug Mechanisms
- Summary
- Section 2: Pharmacology of the Central Nervous System
- Chapter 5. General Principles of Central Nervous System Pharmacology
- CNS Organization
- Cerebrum
- Basal Ganglia
- Diencephalon
- Mesencephalon and Brainstem
- Cerebellum
- Limbic System
- Spinal Cord
- The Blood-Brain Barrier
- CNS Neurotransmitters
- Acetylcholine
- Monoamines
- Amino Acids
- Peptides
- Other Transmitters
- The General Mechanisms of CNS Drugs
- Summary
- Chapter 6. Sedative-Hypnotic and Antianxiety Drugs
- Sedative-Hypnotic Drugs
- Benzodiazepines
- Nonbenzodiazepines
- Pharmacokinetics
- Problems and Adverse Effects of Sedative-Hypnotics
- Antianxiety Drugs
- Benzodiazepines
- Buspirone
- Use of Antidepressants in Anxiety
- Other Antianxiety Drugs
- Problems and Adverse Effects of Anxiolytics
- Summary
- Chapter 7. Drugs to Treat Affective Disorders: Depression and Bipolar Syndrome
- Depression
- Pathophysiology of Depression
- Antidepressant Drugs
- Pharmacokinetics of Antidepressants
- Problems and Adverse Effects
- Antidepressants and Chronic Pain
- Bipolar Disorder
- Lithium
- Other Drugs for Bipolar Disorder
- Summary
- Chapter 8. Antipsychotic Drugs
- Schizophrenia
- Pathogenesis of Schizophrenia
- Neurotransmitter Changes in Schizophrenia
- Antipsychotics Mechanism of Action
- Antipsychotic Drugs
- Traditional Antipsychotics
- Atypical Antipsychotics
- Pharmacokinetics
- Other Uses of Antipsychotics
- Problems and Adverse Effects
- Extrapyramidal Symptoms
- Nonmotor Effects
- Other Side Effects
- Summary
- Chapter 9. Antiepileptic Drugs
- Classification of Epileptic Seizures
- Rationale for Drug Treatment
- Antiseizure Drugs
- First-Generation Antiseizure Drugs
- Second-Generation Agents
- Selection of a Specific Antiepileptic Agent
- Pharmacokinetics
- Special Precautions During Pregnancy
- Treatment of Status Epilepticus
- Withdrawal of Antiseizure Medications
- Summary
- Chapter 10. Pharmacological Management of Parkinson Disease
- Pathophysiology of Parkinson Disease
- Therapeutic Agents in Parkinsonism
- Levodopa
- Pharmacokinetics of Levodopa
- Use of Peripheral Decarboxylase Inhibitors
- Problems and Adverse Effects of Levodopa Therapy
- Drug Holidays From Levodopa
- Other Drugs to Treat Parkinson Disease
- Dopamine Agonists
- Anticholinergic Drugs
- Amantadine
- Monoamine Oxidase B Inhibitors
- Catechol-O-Methyltransferase Inhibitors
- Clinical Course of Parkinson Disease: When to Use Specific Drugs
- Neurosurgical Interventions in Parkinson Disease
- Summary
- Chapter 11. General Anesthetics
- Requirements for General Anesthesia
- Induction Stages of General Anesthesia
- General Anesthetic Agents: Classification and Use According to Route of Administration
- Inhalation Anesthetics
- Intravenous Anesthetics
- Pharmacokinetics
- Mechanism of Action
- Adjuvants in General Anesthesia
- Preoperative Medications
- Neuromuscular Blockers
- Nondepolarizing Blockers
- Depolarizing Blocker
- Summary
- Chapter 12. Local Anesthetics
- Types of Local Anesthetics
- Pharmacokinetics
- Clinical Use of Local Anesthetics
- Topical Administration
- Transdermal Administration
- Infiltration Anesthesia
- Peripheral Nerve Block
- Central Neural Blockade
- Sympathetic Blockade
- Intravenous Regional Anesthesia (Bier Block)
- Mechanism of Action
- Differential Nerve Block
- Systemic Effects of Local Anesthetics
- Summary
- Section 3: Drugs Affecting Skeletal Muscle
- Chapter 13. Skeletal Muscle Relaxants
- Increased Muscle Tone: Spasticity Versus Muscle Spasms
- Antispasm Drugs
- Diazepam
- Centrally Acting Antispasm Drugs
- Antispasticity Drugs
- Baclofen
- Intrathecal Baclofen
- Dantrolene Sodium
- Diazepam
- Gabapentin
- Tizanidine
- Use of Botulinum Toxin as a Muscle Relaxant
- Mechanism of Action
- Clinical Use of Botulinum Toxin
- Limitations and Adverse Effects
- Pharmacokinetics
- Summary
- Section 4: Drugs Used to Treat Pain and Inflammation
- Chapter 14. Opioid Analgesics
- Opioid Analgesics
- Tolerance
- Physical Dependence
- Opioid-Induced Hyperalgesia
- Pharmacological Treatment of Opioid Addiction
- Sources of Opioid Analgesics
- Classification of Specific Agents
- Strong Agonists
- Mild-to-Moderate Agonists
- Mixed Agonist-Antagonists
- Antagonists
- Pharmacokinetics
- Mechanism of Action
- Sites of Opioid Effects
- Effects of Opioids on Synaptic Activity
- Clinical Applications
- Treatment of Pain
- Use of Opioids in Patient-Controlled Analgesia
- Other Opioid Uses
- Problems and Adverse Effects
- Summary
- Chapter 15. Nonsteroidal Anti-Inflammatory Drugs
- Aspirin and other NSAIDs: General Aspects
- Prostaglandins, Thromboxanes, and Leukotrienes
- Eicosanoid Biosynthesis
- Role of Eicosanoids in Health and Disease
- Mechanism of NSAID Action: Inhibition of Prostaglandin and Thromboxane Synthesis
- Aspirin: The Prototypical NSAID
- Clinical Applications of Aspirinlike Drugs
- Treatment of Pain and Inflammation
- Treatment of Fever
- Treatment of Vascular Disorders
- Prevention of Cancer
- Problems and Adverse Effects of Aspirinlike Drugs
- Gastrointestinal Problems
- Cardiovascular Considerations
- Other Side Effects
- Comparison of Aspirin With Other NSAIDs
- COX-2 Selective Drugs
- COX-2 Drugs and the Risk of Heart Attack and Stroke
- Acetaminophen
- Pharmacokinetics of NSAIDs and Acetaminophen
- Summary
- Chapter 16. Pharmacological Management of Rheumatoid Arthritis and Osteoarthritis
- Rheumatoid Arthritis
- Immune Basis for Rheumatoid Arthritis
- Overview of Drug Therapy in Rheumatoid Arthritis
- NSAIDs
- Glucocorticoids
- Disease-Modifying Antirheumatic Drugs
- Traditional (Nonbiological) DMARDs
- Biological DMARDs
- Other DMARDs
- DMARD Combinations Used in Rheumatoid Arthritis
- Dietary Implications for Rheumatoid Arthritis
- Osteoarthritis
- Acetaminophen and NSAIDs
- Viscosupplementation
- Glucosamine and Chondroitin Sulfate
- Summary
- Chapter 17. Patient-Controlled Analgesia
- Pharmacokinetic Basis for PCA
- PCA Dosing Strategies and Parameters
- Types of Analgesics Used for PCA
- PCA Pumps
- Administrations Routes During PCA
- IV PCA
- Epidural
- Regional PCA
- Comparison of PCA to Other Methods of Analgesic Administration
- Comparison of PCA to Continuous Nerve Blocks
- Problems and Adverse Effects of PCA
- Pharmacological Adverse Effects
- Problems With PCA Delivery
- Summary
- Section 5: Autonomic and Cardiovascular Pharmacology
- Chapter 18. Introduction to Autonomic Pharmacology
- Anatomy of the Autonomic Nervous System: Sympathetic and Parasympathetic Divisions
- Preganglionic and Neurons
- Sympathetic Organization
- Parasympathetic Organization
- Functional Aspects of the Sympathetic and Parasympathetic Divisions
- Function of the Adrenal Medulla
- Autonomic Integration and Control
- Autonomic Neurotransmitters
- Acetylcholine and Norepinephrine
- Other Autonomic Neurotransmitters
- Autonomic Receptors
- Cholinergic Receptors
- Adrenergic Receptors
- Pharmacological Significance of Autonomic Receptors
- Summary
- Chapter 19. Cholinergic Drugs
- Cholinergic Receptors
- Cholinergic Stimulants
- Direct-Acting Cholinergic Stimulants
- Indirect-Acting Cholinergic Stimulants
- Clinical Applications of Cholinergic Stimulants
- Problems and Adverse Effects of Cholinergic Stimulants
- Anticholinergic Drugs
- Source and Mechanism of Action of Antimuscarinic Anticholinergic Drugs
- Clinical Applications of Antimuscarinic Drugs
- Problems and Adverse Effects of Anticholinergic Drugs
- Summary
- Chapter 20. Adrenergic Drugs
- Adrenergic Receptor Subclassifications
- Adrenergic Agonists
- Alpha-1-Selective Agonists
- Alpha-2-Selective Agonists
- Beta-1-Selective Agonists
- Beta-2-Selective Agonists
- Drugs With Mixed Alpha- and Beta-Agonist Activity
- Adrenergic Antagonists
- Alpha Antagonists
- Beta Antagonists
- Other Drugs That Inhibit Adrenergic Neurons
- Summary
- Chapter 21. Antihypertensive Drugs
- Normal Control of Blood Pressure
- Pathogenesis of Hypertension
- Essential Versus Secondary Hypertension
- Possible Mechanisms in Essential Hypertension
- Drug Therapy
- Diuretics
- Sympatholytic Drugs
- Vasodilators
- Renin-Angiotensin System Inhibitors
- Calcium Channel Blockers
- Drug Selection for Specific Patients With Hypertension
- Nonpharmacological Treatment of Hypertension
- Summary
- Chapter 22. Treatment of Angina Pectoris
- Drugs Used to Treat Angina Pectoris
- Organic Nitrates
- Beta-Adrenergic Blockers
- Calcium Channel Blockers
- Other Drugs Affecting Myocardial Oxygen Balance in Angina Pectoris
- Use of Anticoagulants in Angina Pectoris
- Treatment of Specific Types of Angina Pectoris
- Stable Angina
- Variant Angina (Prinzmetal Ischemia)
- Unstable Angina
- Nonpharmacological Management of Angina Pectoris
- Summary
- Chapter 23. Treatment of Cardiac Arrhythmias
- Cardiac Electrophysiology
- Cardiac Action Potentials
- Normal Cardiac Rhythm
- Normal Conduction of the Cardiac Action Potential
- Mechanisms of Cardiac Arrhythmias
- Types of Arrhythmias
- Classification of Antiarrhythmic Drugs
- Class I: Sodium Channel Blockers
- Class II: Beta Blockers
- Class III: Drugs That Prolong Repolarization (Potassium Channel Blockers)
- Class IV: Calcium Channel Blockers
- Other Drugs Used to Treat Arrhythmias
- Nonpharmacological Treatment of Arrhythmias
- Summary
- Chapter 24. Treatment of Heart Failure
- Pathophysiology of Congestive Heart Failure
- The Vicious Cycle of Heart Failure
- Congestion in Left and Right Heart Failure
- Pharmacotherapy
- Drugs That Increase Myocardial Contraction Force (Positive Inotropic Agents)
- Digitalis
- Phosphodiesterase Inhibitors
- Dopamine and Dobutamine
- Agents That Decrease Cardiac Workload
- Drugs Affecting the Renin-Angiotensin System
- Beta Blockers
- Diuretics
- Vasodilators
- Summary
- Chapter 25. Treatment of Coagulation Disorders and Hyperlipidemia
- Normal Mechanism of Blood Coagulation
- Clot Formation
- Clot Breakdown
- Drugs Used to Treat Overactive Clotting
- Anticoagulants
- Antiplatelet Drugs
- Fibrinolytics
- Treatment of Clotting Deficiencies
- Hemophilia
- Deficiencies of Vitamin K-Dependent Clotting Factors
- Antifibrinolytics
- Agents Used to Treat Hyperlipidemia
- HMG-CoA Reductase Inhibitors (Statins)
- Fibric Acids
- Other Lipid-Lowering Agents
- Adverse Effects of Antihyperlipidemic Agents
- Summary
- Section 6: Respiratory and Gastrointestinal Pharmacology
- Chapter 26. Respiratory Drugs
- Drugs Used to Treat Respiratory Tract Irritation and Control Respiratory Secretions
- Antitussives
- Decongestants
- Antihistamines
- Mucolytics and Expectorants
- Drugs Used to Maintain Airway Patency in Obstructive Pulmonary Disease
- Beta-Adrenergic Agonists
- Xanthine Derivatives
- Anticholinergic Drugs
- Glucocorticoids
- Cromones
- Leukotriene Inhibitors
- Treatment of Bronchial Asthma
- Pathophysiology of Bronchial Asthma
- Long-Term Management of Asthma
- Treatment of Reversible Bronchospasm in COPD
- Treatment of Respiratory Problems in Cystic Fibrosis
- Summary
- Chapter 27. Gastrointestinal Drugs
- Drugs Used to Control Gastric Acidity and Secretion
- Antacids
- H2 Receptor Blockers
- Proton Pump Inhibitors
- Treatment of Helicobacter Pylori Infection in Gastric Ulcer Disease
- Other Agents Used to Control and Treat Gastric Ulcers
- Antidiarrheal Agents
- Opioid Derivatives
- Bismuth Salicylate
- Miscellaneous Agents Used to Treat Diarrhea
- Laxatives and Cathartics
- Specific Agents and Mechanism of Action
- Adverse Effects
- Miscellaneous Gastrointestinal Drugs
- Digestants
- Emetics
- Antiemetics
- Cholelitholytic Agents
- Summary
- Section 7: Endocrine Pharmacology
- Chapter 28. Introduction to Endocrine Pharmacology
- Primary Endocrine Glands and Their Hormones
- Hypothalamus and Pituitary Gland
- Thyroid Gland
- Parathyroid Gland
- Pancreas
- Adrenal Gland
- Gonads
- Endocrine Physiology and Pharmacology
- Hormone Chemistry
- Synthesis and Release of Hormones
- Feedback Control Mechanisms in Endocrine Function
- Hormone Transport
- Hormone Effects on the Target Cell
- Clinical Use of Endocrine Drugs
- Replacement Therapy
- Diagnosis of Endocrine Disorders
- Treatment of Excessive Endocrine Function
- Exploitation of Beneficial Hormone Effects
- Use of Hormones to Alter Normal Endocrine Function
- Use of Hormones in Nonendocrine Disease
- Summary
- Chapter 29. Adrenocorticosteroids
- Steroid Synthesis
- Glucocorticoids
- Role of Glucocorticoids in Normal Function
- Mechanism of Action of Glucocorticoids
- Physiological Effects of Glucocorticoids
- Clinical Uses of Glucocorticoids
- Glucocorticoid Use in Endocrine Disorders
- Glucocorticoid Use in Nonendocrine Conditions
- Adverse Effects of Glucocorticoids
- Adrenocortical Suppression
- Drug-Induced Cushing Syndrome
- Breakdown of Supporting Tissues
- Other Adverse Effects
- Drugs That Inhibit Adrenocortical Hormone Biosynthesis
- Mineralocorticoids
- Regulation of Mineralocorticoid Secretion
- Mechanism of Action and Physiological Effects of Mineralocorticoids
- Therapeutic Use of Mineralocorticoid Drugs
- Adverse Effects of Mineralocorticoid Agonists
- Mineralocorticoid Antagonists
- Summary
- Chapter 30. Male and Female Hormones
- Androgens
- Source and Regulation of Androgen Synthesis
- Physiological Effects of Androgens
- Clinical Use of Androgens
- Replacement Therapy
- Catabolic States
- Delayed Puberty
- Breast Cancer
- Anemia
- Hereditary Angioedema
- Specific Agents
- Adverse Effects of Clinical Androgen Use
- Antiandrogens
- Androgen Abuse
- Effects of Androgens on Athletic Performance
- Adverse Effects of Androgen Abuse
- Estrogen and Progesterone
- Effects of Estrogen and Progesterone on Sexual Maturation
- Regulation and Effects of Hormonal Synthesis During the Menstrual Cycle
- Female Hormones in Pregnancy and Parturition
- Pharmacological Use of Estrogen and Progesterone
- Conditions Treated With Estrogen and Progesterone
- Use of Hormone Replacement Therapy Following Menopause
- Specific Agents
- Adverse Effects of Estrogen and Progesterone
- Other Drugs That Affect Estrogen and Progesterone Activity
- Selective Estrogen Receptor Modulators
- Antiestrogens
- Antiprogestins
- Hormonal Contraceptives
- Types of Contraceptive Preparations
- Mechanism of Contraceptive Action
- Adverse Effects of Hormonal Contraceptives
- Summary
- Chapter 31. Drugs Affecting Metabolism and Bone Mineralization
- Hormones of the Thyroid Gland
- Synthesis of Thyroid Hormones
- Regulation of Thyroid Hormone Release
- Physiological Effects of Thyroid Hormones
- Mechanism of Action of Thyroid Hormones
- Treatment of Thyroid Disorders
- Hyperthyroidism
- Hypothyroidism
- Parathyroid Hormone
- Regulation of Bone Mineral Homeostasis
- Parathyroid Hormone and Bone Formation
- Vitamin D
- Calcitonin
- Other Hormones
- Pharmacological Control of Bone Mineral Homeostasis
- Calcium Supplements
- Vitamin D
- Bisphosphonates
- Calcitonin
- Estrogen Therapy
- Other Agents That Promote Bone Mineral Content
- Summary
- Chapter 32. Pancreatic Hormones and the Treatment of Diabetes Mellitus
- Structure and Function of the Endocrine Pancreas
- Insulin
- Effects of Insulin on Carbohydrate Metabolism
- Effects of Insulin on Protein and Lipid Metabolism
- Cellular Mechanism of Insulin Action
- Glucagon
- Control of Insulin and Glucagon Release
- Diabetes Mellitus
- Type 1 Diabetes
- Type 2 Diabetes
- Effects and Complications of Diabetes Mellitus
- Use of Insulin in Diabetes Mellitus
- Therapeutic Effects and Rationale for Use
- Insulin Preparations
- Administration of Insulin
- Intensive Insulin Therapy
- Adverse Effects of Insulin Therapy
- Primary Agents in Type 2 Diabetes
- Drugs That Stimulate Insulin Secretion and Supply
- Insulin Sensitizers
- Other Antidiabetics
- Prevention of Type 1 Diabetes Mellitus: The Potential Role of Immune-Based Therapies
- Nonpharmacological Intervention in Diabetes Mellitus
- Dietary Management and Weight Reduction
- Exercise
- Tissue Transplants and Gene Therapy
- Summary
- Section 8: Chemotherapy of Infectious and Neoplastic Diseases
- Chapter 33. Treatment of Infections I: Antibacterial Drugs
- Bacteria: Basic Concepts
- Bacterial Structure and Function
- Pathogenic Effects of Bacteria
- Bacterial Nomenclature and Classification
- Spectrum and Activity of Antibacterial Drugs
- Spectrum of Antibacterial Activity
- Bactericidal Versus Bacteriostatic Activity
- Basic Mechanisms of Antibacterial Drugs
- Inhibition of Bacterial Cell Wall Synthesis and Function
- Inhibition of Bacterial Protein Synthesis
- Inhibition of Bacterial DNA/RNA Synthesis and Function
- Specific Antibacterial Agents
- Antibacterial Drugs That Inhibit Bacterial Cell Wall Synthesis and Function
- Penicillins
- Cephalosporins
- Carbapenems
- Other Agents That Inhibit Bacterial Cell Wall Synthesis
- Use of Beta-Lactamase Inhibitors
- Drugs That Inhibit Bacterial Protein Synthesis
- Aminoglycosides
- Erythromycin and Other Macrolides
- Other Agents That Inhibit Bacterial Protein Synthesis
- Drugs That Inhibit Bacterial DNA/RNA Synthesis and Function
- Aminosalicylic Acid
- Clofazimine
- Dapsone
- Fluoroquinolones
- Metronidazole
- Mupirocin
- Rifamycins
- Sulfonamides
- Trimethoprim
- Other Antibacterial Drugs
- Capreomycin
- Daptomycin
- Isoniazid
- Methenamine
- Nitrofurantoin
- Pyrazinamide
- Clinical Use of Antibacterial Drugs: Relationship to Specific Bacterial Infections
- Resistance to Antibacterial Drugs
- Summary
- Chapter 34. Treatment of Infections II: Antiviral Drugs
- Viral Structure and Function
- Classification of Viruses
- Characteristics of Viruses
- Viral Replication
- Specific Antiviral Drugs
- Acyclovir and Valacyclovir
- Amantadine and Rimantadine
- Cidofovir
- Docosanol
- Dolutegravir, Elvitegravir, and Raltegravir
- Enfuvirtide and Maraviroc
- Famciclovir and Penciclovir
- Foscarnet
- Ganciclovir and Valganciclovir
- Imiquimod
- Trifluridine
- Oseltamivir and Zanamivir
- Protease Inhibitors
- Reverse Transcriptase Inhibitors
- Ribavirin
- Remdesivir
- Viral Resistance
- Interferons
- Synthesis and Cellular Effects of Interferons
- Pharmacological Applications of Interferons
- Adverse Effects of Interferons
- Control of Viral Infection With Vaccines
- HIV and the Treatment of AIDS
- Inhibition of HIV Proliferation in Infected Individuals
- Anti-HIV Drug Combinations: Use of Highly Active Antiretroviral Therapy
- HIV Vaccines
- Management of Opportunistic Infections
- Summary
- Chapter 35. Treatment of Infections III: Antifungal and Antiparasitic Drugs
- Antifungal Agents
- Systemic Antifungal Agents
- Topical Antifungal Agents
- Antiprotozoal Agents
- Antimalarial Agents
- Drugs Used to Treat Protozoal Infections in the Intestines and Other Tissues
- Other Antiprotozoal Drugs
- Anthelmintics
- Albendazole
- Diethylcarbamazine
- Ivermectin
- Mebendazole
- Praziquantel
- Pyrantel Pamoate
- Thiabendazole
- Summary
- Chapter 36. Cancer Chemotherapy
- General Principles
- Cytotoxic Strategy
- Cell-Cycle–Specific Versus Cell-Cycle–Nonspecific Drugs
- Concepts of Growth Fraction and Cell Kill
- Prevalence and Management of Adverse Effects
- Specific Anticancer Drugs
- Alkylating Agents
- Antimetabolites
- Anticancer Antibiotics
- Antimicrotubule Agents
- Topoisomerase Inhibitors
- Anticancer Hormones
- Targeted and Biological Therapies
- Platinum Coordination Complexes
- Aspirin and Other NSAIDs
- Miscellaneous Agents
- Combination Chemotherapy
- Use of Anticancer Drugs With Other Treatments
- Success of Anticancer Drugs
- Resistance to Anticancer Drugs
- Future Perspectives
- Summary
- Chapter 37. Immunomodulating Agents
- Overview of the Immune Response
- Pharmacological Suppression of the Immune Response
- Specific Immunosuppressive Agents
- Azathioprine
- Cyclophosphamide
- Cyclosporine
- Glucocorticoids
- Methotrexate
- Mycophenolate Mofetil
- Sulfasalazine
- Sirolimus and Other mTOR Inhibitors
- Tacrolimus
- Other Methods of Immunosuppression
- Immunostimulants
- Bacille Calmette-Guérin
- Immune Globulin
- Other Immunomodulators
- Summary
- Chapter 38. Complementary and Alternative Medications
- Problems Associated With CAMs
- Misconceptions About CAM Safety
- Failure to Report CAM Use
- Lack of Standards for Quality and Purity of CAMs
- Delayed Use of Conventional Medications
- Potential Adverse Effects of CAMs
- Specific CAMs
- Bee Venom
- Echinacea
- Garlic
- Ginger
- Ginkgo Biloba
- Ginseng
- Glucosamine and Chondroitin
- Kava
- Melatonin
- Saw Palmetto
- St. John’s Wort
- Valerian
- Vitamins and Minerals
- Vitamins
- Minerals
- Summary
- Appendix A Drugs Administered by Iontophoresis and Phonophoresis
- Appendix B Drugs of Abuse
- Appendix C Answers to Case Study Questions
- Glossary
- Index